| Market Cap | ₹21,174Cr |
| ROE | 2.23% |
| P/E Ratio(TTM) | 310.73 |
| EPS(TTM) | 5.95 |
| P/B Ratio | 3.58 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.58 |
| Book Value | 516.93 |
| Debt to Equity | 0.16 |
| Face Value | 1 |
| Parent Organisation | Onesource Specialty Pharma |
| NSE Symbol | ONESOURCE |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Biocon | NA (0.00%) | 74.48 | ||
| Anthem Biosciences | NA (0.00%) | 92.31 | ||
| Advanced Enzyme Technologies | NA (0.00%) | 25.24 | ||
| Panacea Biotec | NA (0.00%) | 244.04 |